ENANTA PHARMACEUTICALS, INC Operating Lease, Weighted Average Discount Rate, Percent
ENANTA PHARMACEUTICALS, INC (ENTA) had Operating Lease, Weighted Average Discount Rate, Percent of 8.80% as of 2025-09-30, per its 10-K filed 2025-11-19.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2025-11-19
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 8.80%.
- 2024-09-30: Operating Lease, Weighted Average Discount Rate, Percent 8.80%.
- 2023-09-30: Operating Lease, Weighted Average Discount Rate, Percent 7.20%; Operating Lease, Weighted Average Discount Rate, Percent as first filed 7.18%.
- 2022-09-30: Operating Lease, Weighted Average Discount Rate, Percent 6.96%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2025-09-30 | 8.80% 10-K · filed 2025-11-19 | |
| 2024-09-30 | 8.80% 10-K · filed 2025-11-19 | |
| 2023-09-30 | 7.20% 10-K · filed 2024-11-27 | 7.18% 10-K · filed 2023-11-22 |
| 2022-09-30 | 6.96% 10-K · filed 2023-11-22 | |
| 2021-09-30 | 6.08% 10-K · filed 2022-11-23 | |
| 2020-09-30 | 6.50% 10-K · filed 2021-11-24 | |
| 2020-06-30 | 6.50% 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 6.50% 10-Q · filed 2020-05-11 | |
| 2019-12-31 | 6.50% 10-Q · filed 2020-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |